Debi Weiss went to the doctor's office with what she thought were worsening flu symptoms, but got a very different diagnosis ...
What seemed like a simple illness turned into a life-changing diagnosis for Debi Weiss, a 72-year-old Pilates instructor who later discovered she had an aggressive form of cancer. Her journey through ...
Giahan Tang thought she was finally finding stability after college when unusual symptoms led to a shock diagnosis of stage 4 diffuse large B-cell lymphoma After an ER visit initially blamed on an ...
Real-time ctDNA MRD testing guides early chemo de-escalation in diffuse large B-cell lymphoma, aiming to cut toxicity without losing cure rates. In an interview with Targeted Oncology, Hua-Jay “Jeff” ...
Zacks Investment Research on MSN
Will GILD's move to acquire ACLX boost its cell therapy franchise?
Gilead Sciences, Inc.’s GILD Cell Therapy franchise currently comprises Yescarta and Tecartus. Sales from this unit decreased 7% year over year to $1.8 billion (in 2025) due to ongoing competitive ...
HealthDay News — Features that characterize presentation of vitreoretinal lymphoma are described in an article published online March 1 in Clinical & Experimental Ophthalmology.
ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...
Operator: Hello, and thank you for standing by. Welcome to Allogene Therapeutics, Inc. Fourth Quarter 2025 Conference Call.
G&A Expenses -- $13.8 million in the fourth quarter, of which $5.6 million was non-cash stock-based compensation; annual G&A ...
Abstract: The channel state information (CSI) acquisition plays a pivotal role in cell-free (CF) massive multiple-input-multi-output (mMIMO) systems. However, conventional pilot-based channel ...
Readers will learn how veterinary oncologists stage and treat canine lymphoma using modern multi-agent chemotherapy and palliative care.
Patient dosing has commenced in first-of-its-kind Phase 3 head-to-head CAR T-cell 2L randomized controlled clinical trial (PiNACLE-H2H) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results